ArticleJournal of gastroenterology2019

Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection.

Goki Suda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.